Latest for Myelodysplastic Syndromes
See all trialsThe week in rare diseaseEach date is the day a change was posted. Open an item to see where things stand now.
- Trial statusNo longer enrolling. IS-free Treg HaploHCT (Phase 1, Dana-Farber Cancer Institute)ClinicalTrials.gov
- Trial statusNo longer enrolling. Venetoclax Basket Trial for High Risk Hematologic Malignancies (Phase 1, Andrew E. Place, MD)ClinicalTrials.gov
- Trial statusNo longer enrolling. Vitamin A and D Supplementation in Allogeneic HCT (Phase 2)ClinicalTrials.gov
More about Myelodysplastic Syndromes
Treatment depends on the MDS subtype and risk category. Lower-risk MDS is often managed with supportive care including transfusions and growth factors like erythropoiesis-stimulating agents. Luspatercept (Reblozyl) is FDA-approved for anemia in lower-risk MDS, both as a first treatment in patients who have not had an erythropoiesis-stimulating agent and for patients with ring sideroblasts after an ESA has failed.
Keep reading about Myelodysplastic Syndromes
Higher-risk MDS is treated with hypomethylating agents (azacitidine, decitabine) and, in eligible patients, allogeneic stem cell transplantation, which remains the only potentially curative approach. Molecular profiling including mutations in SF3B1, TP53, and other genes increasingly guides treatment selection and prognosis.
What are the symptoms of Myelodysplastic Syndromes?
These are common symptoms of Myelodysplastic Syndromes, and how strong they are varies from person to person.
- Fatigue and weakness from anemia
- Shortness of breath during normal activities
- Easy bruising or unusual bleeding
- Frequent or severe infections
- Pale skin appearance
- Petechiae (small red or purple spots under the skin)
Who gets Myelodysplastic Syndromes?
Primarily affects older adults, with the average age at diagnosis between 70 and 75. Slightly more common in males and in those of European descent. Risk factors include prior chemotherapy or radiation therapy, exposure to benzene or other industrial chemicals, and smoking. Very rare in children.
Next steps: find trials you might fitsee approved treatmentsget help payingget alerts
Which medicines are FDA-approved for Myelodysplastic Syndromes?
There are currently 8 FDA-approved medications for Myelodysplastic Syndromes.
Source: openFDA drug labeling data. This list may not include all treatments. Always consult your doctor.
How to get help paying for Myelodysplastic Syndromes treatment
Charity funds and drugmaker programs for Myelodysplastic Syndromes, checked at the source.
- From a charity · Blood Cancer United (formerly The Leukemia & Lymphoma Society)Clinical Trials Co-Pay Fund (all blood cancers) fundOpen
Pays for: Insurance premiums and treatment-related copays, deductibles and coinsurance, up to $3,500 per year. Requires health insurance (any kind).
- From a charity · Blood Cancer United (formerly The Leukemia & Lymphoma Society)Patient Aid Program fundOpen
Pays for: One-time $100 stipend for non-medical expenses (transportation, food, housing, utilities); no income or insurance requirement, up to $100 per year.
The foundation says: “CURRENT FUND STATUS: Open. Fund is currently Open.” - From a charity · HealthWell FoundationMyelodysplastic Syndromes (Medicare Access) fundOpen
Pays for: Copays, premiums or other treatment costs. Medicare patients only.
- Rytelo (Imetelstat) · REACH4RYTELO
- Reblozyl (Luspatercept) · BMS Access Support
- Revlimid (Lenalidomide) · BMS Access Support
- Vidaza (Azacitidine) · BMS Access Support and Bristol Myers Squibb Patient Assistance Foundation (Vidaza brand only)
- Inqovi (Decitabine and cedazuridine) · Taiho Oncology Patient Support
- Tibsovo (Ivosidenib) · ServierONE
Every program and fund for Myelodysplastic Syndromes, by insurance →
Side effects people have reported to the FDA
Side effects people have reported to the FDA
Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.
Loading side effect data...
Diagnosis and genetic testing
Genetic testing for Myelodysplastic Syndromes
Genetic testing can confirm a diagnosis, guide treatment decisions, and identify family members who may be at risk.
Finding labs...
Trusted Myelodysplastic Syndromes resources
Reputable organizations and medical references for learning more about Myelodysplastic Syndromes, including disease registries, foundation resources, and clinical guidelines.